EyeGene,Inc
Develops gene/cell therapies for age-related diseases and preventive vaccines.
185490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185490000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 양지편2로 13 2층, 의왕시
- Website:
- https://eyegene.co.kr/en/
Description
EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
증권신고서(지분증권) (2025.11)
|
Korean | 1.8 MB | ||
| 2025-09-16 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 32.6 KB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-06-30 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정) (4가 수막구균 접합백신 ‘EGMCV4의 국내 임상 제2/3상 임상시…
|
Korean | 17.9 KB | ||
| 2025-05-15 00:00 |
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-05-12 00:00 |
주식매수선택권부여에관한신고
|
Korean | 18.1 KB | ||
| 2025-03-26 00:00 |
정기주주총회결과
|
Korean | 21.4 KB | ||
| 2025-03-18 00:00 |
감사보고서제출
|
Korean | 26.5 KB | ||
| 2025-03-18 00:00 |
사업보고서 (2024.12)
|
Korean | 1.7 MB | ||
| 2025-03-11 00:00 |
의결권대리행사권유참고서류
|
Korean | 158.3 KB | ||
| 2025-03-10 00:00 |
주주총회소집공고
|
Korean | 159.1 KB | ||
| 2025-03-04 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청) (EGMCV4수막구균(혈청형 A, C, W135 및 Y군) 접합백신의 면역…
|
Korean | 12.1 KB | ||
| 2025-02-28 00:00 |
투자판단관련주요경영사항(임상시험결과) (아이진 mRNA 기반 코로나19 예방백신 (EGCOVID) ‘이지코비드(EGC…
|
Korean | 14.5 KB | ||
| 2025-02-28 00:00 |
투자판단관련주요경영사항(임상시험결과) (mRNA 기반 코로나19 예방 다가백신 이지코브투(EGCOVII) 호주 임상 제…
|
Korean | 14.9 KB | ||
| 2025-02-26 00:00 |
투자판단관련주요경영사항(임상시험계획자진취하등) (4가 수막구균 접합백신 ‘EGMCV4의 국내 임상 3상 임상시험계획(I…
|
Korean | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EyeGene,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EyeGene,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
